Andrew Storey AbbVie

Andrew Storey has 30 years in the pharmaceutical industry providing leadership for Regulatory Affairs. He is presently Vice President, Global Regulatory Strategy for AbbVie and was a senior executive with global responsibilities for the previous 14 years at Cangene (Toronto) and CBL (Baltimore). Prior to that he held several regulatory positions in small biotech companies. He has led the development of many innovative products and therapies and also successfully licensed a biosimilar product in the US in 2008. Post 9/11, he spent 11 years working on the development of Medical Countermeasures to Bioterrorism and worked with CDC, NIH and BARDA to install multiple biodefense products into the US Strategic National Stockpile (SNS) as well as in other global stockpiles . He is presently working on exciting challenges related to the Humira, and Viekira Pak franchises, as well as a comprehensive pipeline of products at AbbVie.